Master Alliance Provisions Guide (MAPGuide)

NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement

  • Business model | Product supply
  • Equitable Access | Territory access commitments

<p><span style=”textdecoration: underline;”><strong>10. Performance And Diligence Obligationsstrong>span>p>
<p>[&#8230;]p>
<p><strong>10.2strong> The Licensee agrees, after its First Commercial Sale, to make reasonable quantities of Licensed Products available to patient assistance programs in the Licensed Territory [Worldwide], to the extent commercially reasonable and without otherwise harming the business interests or viability of Licensee.p>